These findings provide evidence that SIRT1 reduction links vascular senescence through vascular inflammation to AAAs and that SIRT1 in VSMCs is a promising therapeutic target for the prevention of life-threatening aortic diseases. The gene discussed is SIRT1; the disease is achalasia-alacrima syndrome.